Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study.

Saved in:
Bibliographic Details
Title: Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study.
Authors: Tanimine N; Department of Gastroenterological and Transplant Surgery, Hiroshima University, Higashihiroshima, Japan., Markmann JF; Penn Transplant Institute, Philadelphia, Pennsylvania, USA., Wood-Trageser MA; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Demetris AJ; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mason K; Rho, Durham, North Carolina, USA., Silva JAF; Emory Transplant Center, Emory University, Atlanta, Georgia, USA; Immune Tolerance Network, Seattle, Washington, USA., Levitsky J; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Feng S; Department of Surgery, University of California-San Francisco, San Francisco, California, USA., Humar A; Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Emond JC; Department of Surgery, Columbia University Irving Medical Center, New York, New York, USA., Shaked A; Department of Gastroenterological and Transplant Surgery, Hiroshima University, Higashihiroshima, Japan., Klintmalm G; Department of Surgery, Baylor University Medical Center, Dallas, Texas, USA., Sanchez-Fueyo A; Institute of Liver Studies, King's College Hospital, Medical Research Council (MRC) Centre for Transplantation, King's College London University, London, UK., Lesniak D; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Breeden CP; Emory Transplant Center, Emory University, Atlanta, Georgia, USA; Immune Tolerance Network, Seattle, Washington, USA., Nepom GT; Immune Tolerance Network, Seattle, Washington, USA., Bridges ND; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Goldstein J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Larsen CP; Emory Transplant Center, Emory University, Atlanta, Georgia, USA; Immune Tolerance Network, Seattle, Washington, USA., DesMarais M; Immune Tolerance Network, Seattle, Washington, USA., Gaile G; Immune Tolerance Network, Seattle, Washington, USA., Chandran S; Immune Tolerance Network, Seattle, Washington, USA. Electronic address: schandran@immunetolerance.org.
Source: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2025 May; Vol. 25 (5), pp. 1030-1044. Date of Electronic Publication: 2024 Nov 04.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-6143 (Electronic) Linking ISSN: 16006135 NLM ISO Abbreviation: Am J Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1600-6143
DOI:10.1016/j.ajt.2024.10.022